GSK begins cancer cell therapy tie-up with ImmaticsCancer biotech Immatics has begun a collaboration with GlaxoSmithKline to develop novel therapies built around its T-cell-based technology. Share XGSK begins cancer cell therapy tie-up with Immaticshttps://pharmaphorum.com/news/gsk-begins-cancer-cell-therapy-tie-up-with-immatics/
Change at the top at Adaptimmune as Noble stands downThe long-serving CEO and founder of UK biotech Adaptimmune, James Noble, is standing down, to be replaced by Share XChange at the top at Adaptimmune as Noble stands downhttps://pharmaphorum.com/news/change-at-the-top-at-adaptimmune-as-noble-stands-down/
Kite outlines vision for next gen cancer killing cellsBacked by Amgen, Kite outlines bold plan for developing CAR-T and TCR cells. Share XKite outlines vision for next gen cancer killing cellshttps://pharmaphorum.com/news/kite-outlines-vision-next-gen-cancer-killing-cells/